A Biotechnology Startup inokudziridza mishonga yakagadzirirwa kubvisa mapuroteni anotyisa anowanikwa kunze kwemasero akasimudza madhora zana nemakumi matatu emamiriyoni ekutanga kiriniki yayo yekutanga.
Kutanga, Glycoera, achashandisa iyo nhevedzano b mari yekugadzira yekutanga kiriniki data yechirongwa chake chekutungamira, kurapwa kwemuviri kurapwa kwakaitwa GECBED GE8820. Zvinoda kuunza chechipiri chishandiso chekushandisika mukuedzwa kwevanhu zvakare.
Glycoera anotarisa GE8820 sekuve nerudzi rwezvakakura zvinogona kuita kuti riite "pombi yechigadzirwa," akadaro kambani commure uye CEO Ganesh Kaundhya. Zvinangwa zvezvinodhaka Igg4, kutenderera kunamatira kunogona kudzivirira kurwisa allergies, asi kushaya simba uye kurwisa matikiti emuviri mukati Mazhinji autoimmune mamiriro, pakati pavo chirwere cheganda cheganda pemphigus uye iyo itsvo mamiriro ekutanga membranous nephropathy.
GE8820 izuva rezuva - Kuita zvinodhaka kunowisira muviri muparadzi iyi yakaremara igg4. Chikamu chimwe cheMorekuru ngaasungirwe kumanyokwi uye anozvidzora kune chiropa. Chimwe chikamu chimwe chikamu chazotambisa pane regrok iyo inobata igg4 kuita masero, uko kwarinoitwa neyeprotein yemukati - kurasa hurongwa hwemukati -
Sekureva kweGlycoera, preclinical kuongororwa kwaratidza kuti nzira yacho inogona kubvisa malfunctioning igg4 antibodies ane mikana yekufungidzira haina kuonekwa neimwe nzira. Nekuita izvi, GE8820 inogona kudzivirira iyo yakawedzera immunosupppress mhedzisiro yemimwe mishonga ye autoimmune. Izvo zvinogona zvakare kurerutsa "mutoro pane hutano hwehutano," Kandinya akadaro.
Varwere kazhinji "vanobatwa, ivo vanazvo, vakanaka, uye vanobva vadzoka kudzokerazve," Kandinya akadaro. "Maitiro edu asingangoita kuti varwere vagare hupenyu huri nani hupenyu, hwakazara hunopa zvinopa kune hutano hwehupfumi hupfumi."
Glycoera akatambanudzwa pachena mamwe matatu mapurogiramu ari kumashure kweGe8820, asi haana kutaura kuti ndezvipi zvirwere zvavari kunakidza. Iyo kambani inogona kuendesa chikumbiro chekutanga miedzo yemishonga yechipiri mu 2026, Zvinoenderana newebhusaiti yayo.
NOvo Holdings LED SELSE SEVELED B Round B kutenderera, iyo yaisanganisira kusimuka kwemaoko emuchero uye bristol vigers squibb, sofinnova vabati uye mamwe mafemu akati wandei.
"Chii chaimudzwa neGlycoera ndechekuti iwe wakamboita nyaya yekushandisa pano uko, muAximmune Chirwere, pane huwandu hwakaenzana hwekurapa hwakanyanya," akadaro Novo novo midhofu yemunhu max klement. "Sezvatinoona iyo autoimmune chirwere chezvirwere zvinoitika, precision mushonga anogadzira seGlycoera achauya kumberi."
Glycoera anotumidzwa zita rake mushure meGlycosylation, maitiro ayo ayo maketani ane shuwa akasungirirwa nemapuroteni. Iyo kambani iri kutakura musoro muWIDENSwil, Switzerland uye ine U.S. tsoka yeUston muNewton, Massachusetts. Yakanga ichisimuka kunze kweSwitzerland biotech limmatech biologics mukati Ndira 2021, uye akarerwa anenge madhora makumi matatu nemashanu emamiriyoni Muzvikamu zvemari iyo yaNovember.
Iyo kambani yazvino kutenderera ndeye humwe humbowo hwekuenderera mberi kufarira saka - Inonzi puroteni mashisheni, iyo inopa nzira yekuve nemapuroteni echinyakare drugming nzira hadzigone kusvika. Tsvagiridzo mumidziyo yeProtein yakabviswa kubvira tendeuka kwezana remakore, kutevedzera makambani anoshandisa Nzira dzakasiyana kuti Paradza mapuroteni anokuvadza.
ONA:Yakadzoserwa kubva ku biophagremu. Kana paine chero copyright ine hanya, ndapota bvunza timu yewebhusaiti yekubvisa.
Post Nguva: 2025 - 05 - 30 11:23:56
